Regulating antimicrobial sales in Saudi Arabia: Achievements and challenges

Abstract

Background Antimicrobials save millions of lives annually from dying because of bacterial infections, but the rapid emergence of antimicrobial resistance (AMR) becomes a global threat. The Saudi Ministry of Health (MOH) has taken containment measures to limit the misuse of antimicrobials via implementing restrictions on dispensing without prescriptions. Hence, we aim to evaluate the impact of regulating antimicrobial sales and identify challenges that pharmacists are facing to prevent self‐medication with antimicrobial agents. Materials and Methods A cross‐sectional study was conducted using two sources of data: sales reports from 3000 pharmacies in Saudi Arabia and a self‐designed questionnaire. The questionnaire consists of 24 items written in English and Arabic languages, went through multiple steps to ensure validity and reliability and then distributed online. Descriptive analyses were used to present the results. Results A total of 106 pharmacists completed the questionnaire. Sixty‐three per cent of the respondents observed a reduction of 40% in sales, which was consistent with pharmacies’ sales reports, which revealed a 50% reduction in 2018 as compared to 2017. Seventy‐six per cent of respondents agreed that antimicrobials’ sales restrictions were frustrating to patients. The percentage of pharmacists who reported receiving prescriptions with complete information about patients, prescribers, medications and issue date was 70%, 54%, 86% and 77%, respectively. And 69% of respondents revealed receiving support from their employers to prevent dispensing antimicrobial agents without prescription. Conclusion Restriction measures implemented by the Saudi MOH led to a 40% to 50% reduction in inappropriate sales of antimicrobials. Further studies are needed to investigate the methods for improving documentation and prescribing practices.

Antibiotics’ Use in Thailand: Community Pharmacists’ Knowledge, Attitudes and Practices

“…Community pharmacists in particular are key drivers to improving antimicrobial stewardship in contexts like Thailand, where pharmacies are the most cost-effective, accessible and sometimes the only healthcare provider available [ 10 , 11 , 12 , 13 ]. Evidence support the impact of pharmacists’ interventions on reducing antimicrobial resistance [ 12 , 14 , 15 , 16 ]. However, evidence also indicate that in countries and settings where antimicrobial resistance rates are soaring, pharmacists may lack awareness and can have inadequate knowledge of antimicrobial resistance.…”

Impact of Positive Culture Reports of E. coli or MSSA on De-Escalation of Antibiotic Use in a Teaching Hospital in Pakistan and the Implications

“…1 In most cases, antibiotic-resistant pathogens are responsible for nosocomial infections, which have risen due to excessive use of broad-spectrum antibiotics. [2][3][4][5][6] This is a concern as the development of new antibiotics and repositioning of old antibiotics has slowed. 3,7 Alongside this, the Centers for Disease Control and Prevention (CDC) recognized that 20-50% of all antibiotics prescribed to patients in critical care hospitals in the US are either redundant or inappropriate.…”

Evaluating the effectiveness of the Ministry of Health restriction policy on seasonal antibiotic consumption trends in Saudi Arabia, 2016–2020

“…Similarly, inadequate knowledge and poor practices among healthcare professionals have been reported ( Alzahrani et al, 2020 ; Baraka et al, 2021 ). In 2016, it was reported that the pharmaceutical expenditure in Saudi Arabia reached 7 billion US dollars, with nearly 2 billion US dollars spent on antibiotics ( Almeleebia et al, 2021 ).…”